Search results:
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Pholcodine | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | New Zealand | OTC | In medicines for oral use containing not more than 15mg of pholcodine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100mg of pholcodine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine. |
| Butamirate citrate | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | New Zealand | — | No information. |
| Atovaquone/Proguanil | P Antiparasitic products, insecticides and repellents. Antiparasitic products, insecticides and repellents | P01. Antiprotozoals | — | New Zealand | — | No information. |
| Sildenafil | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | New Zealand | OTC | — |
| Aciclovir (systemic use) | J Antiinfectives for systemic use. Antiinfectives for systemic use | J05. Antivirals for systemic use | — | New Zealand | — | No information. |
| Adapalene | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | New Zealand | — | No information. |
| Dexketoprofen | M Musculo-skeletal system. Musculo-skeletal system | M01. Antiinflammatory and antirheumatic products | — | New Zealand | — | No information. |
| Valaciclovir | J Antiinfectives for systemic use. Antiinfectives for systemic use | J05. Antivirals for systemic use | — | New Zealand | — | No information. |
| Econazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | — | New Zealand | — | No information. |
| Fusafungine | R Respiratory system. Respiratory system | R02. Throat preparations | — | New Zealand | — | No information. |
| Ulipristal acetate | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G03. Sex hormones and modulators of the genital system | — | New Zealand | — | No information. |
| Oxitriptan | N Nervous system. Nervous system | N06. Psychoanaleptics | — | New Zealand | — | No information. |
| Yohimbine | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | New Zealand | — | No information. |
| Cetrimide | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | New Zealand | — | No information. |
| Azelaic acid | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | New Zealand | — | No information. |
| Diosmin | C Cardiovascular system. Cardiovascular system | C05. Vasoprotectives | — | New Zealand | — | No information. |
| Metronidazole | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | New Zealand | — | No information. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | — | No information. |
| Antazoline | S Sensory organs. Sensory organs | S01. Ophthalmologicals | — | New Zealand | — | No information. |
| Neomycin sulfate | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | New Zealand | — | No information. |
| Diosmectite | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | — | New Zealand | — | No information. |
| Alverine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | — | No information. |
| Chlorhexidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A01. Stomatological preparations | — | New Zealand | — | No information. |
| Chloroxylenol | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | New Zealand | — | No information. |
| Isoconazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | — | New Zealand | — | No information. |
| Esomeprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | — | No information. |
| Trimethoprim | J Antiinfectives for systemic use. Antiinfectives for systemic use | J01. Antibacterials for systemic use | — | New Zealand | OTC | OTC in medicines for oral use containing 300mg or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16-65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists' training in the treatment of urinary tract infections. |
| Oxybutynin | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | New Zealand | OTC | — |
| Lodoxamide | S Sensory organs. Sensory organs | S01. Ophthalmologicals | — | New Zealand | OTC | Pharmacy-only. |
| Guaifenesin | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | New Zealand | OTC | General sales for oral use in medicines containing 2% or less or 200mg or less per dose form; for oral use in modified release form with a maximum recommended daily dose of not more than 2.4g when sold in the manufacturer's original pack containing not more than 10 days' supply. Pharmacist-only for oral use in modified release form with a maximum recommended daily dose of not more than 2.4g when sold in the manufacturer's original pack containing more than 10 days' supply but not more than 30 days' supply. |
| Erdosteine | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | New Zealand | N.R. | Not registered or not marketed. |
| Racecadotril | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | — | New Zealand | N.R. | Not registered or not marketed. |
| Strontium chloride (toothpaste) | Non-classified -. - | n. a. | — | New Zealand | OTC | General sale. |
| Potassium nitrate (toothpaste) | Non-classified -. - | n. a. | — | New Zealand | OTC | — |
| Decaline | Non-classified -. - | n. a. | — | New Zealand | N.R. | Not registered or not marketed. |
| Bronopol | Non-classified -. - | n. a. | — | New Zealand | N.R. | Not registered or not marketed. |
| Polymyxin B (topical) | S Sensory organs. Sensory organs | S03. Ophthalmological and otological preparations | — | New Zealand | Rx | — |
| Chloramphenicol | S Sensory organs. Sensory organs | S03. Ophthalmological and otological preparations | 2010 | New Zealand | OTC | Chloramphenicol for ophthalmic use was switched from prescription to pharmacist-only status in May 2010, except when sold in practice by a registered optometrist. |
| Sulfacetamide (topical) | S Sensory organs. Sensory organs | S01. Ophthalmologicals | — | New Zealand | OTC | — |
| Trip(r)olidine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | Harmonisation of schedules of Australia and New Zealand. See note under Australia. |
| Tripelennamine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | N.R. | Not registered or not marketed. |
| Promethazine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | Harmonisation of schedules of Australia and New Zealand. See note under Australia. |
| Oxatomide | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | N.R. | Not registered or not marketed. |
| Mequitazine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | Rx | — |
| Mepyramine maleate | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | — |
| Meclozine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | Maximum 12 tablets pharmacy only or when sold at transport terminal or on a ship or plane. |
| Loratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | — |
| Levocetirizine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | For oral use. |
| Ketotifen | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | OTC | Ophthalmic use. 0.025% or less. |
| Fexofenadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2010 | New Zealand | OTC | Fexofenadine was approved for distribution as a general sale medicine in 2010 in capsules containing 60mg or less of fexofenadine hydrochloride or in tablets containing 120mg or less of fexofenadine hydrochloride when sold in a pack approved by the Minister or the Director-General. Higher dosages are pharmacy-only medicines. |
- Page 1 of 6
- Next
- 50 of 263 ingredients